This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Opus Nv, Vrije Universiteit Brussel. Active years: 2009.
Company Filing History:
1 out of 1 
1 out of 190 
Years Active: 2009
Title: Luc Baeyens: Innovator in Diabetes Treatment
Introduction
Luc Baeyens is a notable inventor based in Buggenhout, Belgium. He has made significant contributions to the field of diabetes treatment through his innovative research and patents. His work focuses on the differentiation of pancreatic cells, which has the potential to improve the lives of those suffering from diabetes.
Latest Patents
Luc Baeyens holds a patent for a method of generating islet beta-cells from exocrine pancreatic cells. This invention discloses an in vitro method wherein mammalian beta-cell differentiation can be induced in dedifferentiated exocrine pancreatic cells. The method utilizes a medium comprising ligands of the EGF receptor and the GP130 receptor, such as EGF and LIF. The insulin-secreting cells obtained through this method provide a promising means for the treatment of diabetes via islet transplantation. He has 1 patent to his name.
Career Highlights
Throughout his career, Luc Baeyens has worked with esteemed institutions, including Vrije Universiteit Brussel and Opus NV. His research has been pivotal in advancing the understanding of pancreatic cell differentiation and its applications in diabetes treatment.
Collaborations
Luc Baeyens has collaborated with notable professionals in his field, including Luc Bouwens. Their joint efforts have contributed to the development of innovative solutions for diabetes management.
Conclusion
Luc Baeyens is a distinguished inventor whose work in generating insulin-secreting cells from pancreatic cells holds great promise for diabetes treatment. His contributions to the field are invaluable and continue to inspire future research and innovation.